Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravis

G. A. Nicholson*, L. R. Griffiths

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)


    The relationship of acetylcholine receptor (AchR) antibodies to disease activity in myasthenia gravis (MG) is controversial. Some authors claim a direct correlation with disease activity and treatment, in particular plasmapheresis therapy, whereas others have commented on the poor overall correlation of antibody levels with clinical state. Antibody levels were examined in a population of MG patients and correlated with disease activity and response to treatment. Antibodies to skeletal muscle AchR were found in most patients with generalised MG (24/25) and in about half of the patients with purely ocular MG (6/10) and in neither of 2 patients with congenital MG. There was scant correlation with disease activity or response to treatment. It is concluded that the assay is more useful for diagnosis than for management of MG.

    Original languageEnglish
    Pages (from-to)61-69
    Number of pages9
    JournalClinical and experimental neurology
    Publication statusPublished - 1981


    Dive into the research topics of 'Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravis'. Together they form a unique fingerprint.

    Cite this